Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: A retrospective study

Internal Medicine Journal

Volumn 44, Issue 2, 2014, Pages 139-147

  Gifford, G ^a   Sim, J ^b   Horne, A ^a   Ma, D ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Allogeneic bone marrow transplantation; Health status; Late effect; Lifelong surveillance; Long term survivorship; Quality of life

Indexed keywords

ADULT; AUSTRALIA; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEALTH CARE DELIVERY; HEALTH DISPARITY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; SURVIVOR; TIME;

ADULT; AUSTRALIA; BONE MARROW TRANSPLANTATION; DELIVERY OF HEALTH CARE; FEMALE; GRAFT VS HOST DISEASE; HEALTH STATUS DISPARITIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TIME;

EID: 84894099097     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12336     Document Type: Article

References (33)

1. Nivison-Smith I, Dodds AJ, Dunckley H, Ma DD, Moore JJ, Simpson JM etal. Increased activity and improved outcome in unrelated donor haemopoietic cell transplant for acute myeloid leukaemia in Australia, 1992-2005. Intern Med J 2011; 41: 27-34.
2. Nivison-Smith I, Simpson JM, Dodds AJ, Ma DDF, Szer J, Bradstock KF. Relative survival of long-term haematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Trasplant 2009; 15: 1323-1330.
3. Martin PJ, Counts GW Jr, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ etal. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011-1016.
4. Savani BN, Griffith ML, Jagasia S, Lee SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood 2011; 117: 3002-3009.
5. Tichelli A, Rovo A, Gratwohl A. Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Am Soc Hematol Educ Prog 2008; 2008: 125-133.
6. Tichelli A, Schwarze C-P, Socie G. Long term survivorship, general health status, quality of life and late complications after HSCT. In: Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T, eds. EBMT (European Group for Bone Marrow Transplantation) Handbook. Genoa: Forum Service Editore; 2008; 236-253.
7. Mohty M, Apperley JF. Long-term physiological side effects after allogeneic bone marrow transplantation. Haematology Am Soc Hematol Educ Program 2010; 2010: 229-236.
8. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ etal. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138-151.
9. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C etal. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012; 47: 337-341.
10. Sun CL, Francisco L, Kawashima T, Leisenring W, Leslie L, Robison K etal. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 2010; 116: 3129-3139.
11. Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S. Adverse Psychological outcome in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 2011; 118: 4723-4731.
12. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME etal. Recovery and long-term function after hematopoietic cell transplantation for leukaemia or lymphoma. JAMA 2004; 291: 2335-2343.
13. Janda M, DiSipio T, Hurst C, Cella D, Newman B. The Queensland Cancer Risk Study: general population norms for the Functional Assessment of Cancer Therapy-General Population (FACT-GP). Psychooncology 2009; 18: 606-614.
14. Wingard JR, Majhail JS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D etal. Long term survival and late deaths after allogeneic hematopoiectic cell transplantation. J Clin Oncol 2011; 29: 2230-2239.
15. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ etal. Long term health related quality of life, growth, and spiritual well-being after haematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599-608.
16. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD etal. Quality of Life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129-1136.
17. Bourchier M. Cardiovascular Disease Australian Facts 2011. Cardiovascular, Diabetes and Kidney Unit at the Australian Institute of Health and Welfare. Presentation at the 2011 National Heart Foundation Conference, Melbourne, 17 June 2011.
18. Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T etal. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working party of the European Group for Blood and Marrow Transplantation. Haematologica 2008; 93: 1203-1210.
19. Brennan BM, Shalet SM. Endocrine late effects after bone marrow transplant. Br J Haematol 2002; 118: 58-66.
20. Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ etal. Diabetes, hypertension and cardiovascular events in survivors of haematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 2007; 109: 1765-1772.
21. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
22. de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol 2010; 11: 193-203.
23. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K etal. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172.
24. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric haematopoietic cell transplantation. J Pediatr Hematol Oncol 2004; 26: 81-90.
25. National Vascular Disease Prevention Alliance. Guidelines for the assessment and management of absolute cardiovascular disease (CVD) risk. 2012 [cited 2012 May 19]. Available from URL: http://www.heartfoundation.org.au/information-for-professionals/Clinical-Information
26. Ebeling P. Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab 2009; 94: 1483-1490.
27. Choi M, Sun CL, Kurian S, Carter A, Francisco L, Forman SJ etal. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 2008; 113: 1580-1587.
28. Kersting S, Hené RJ, Koomans HA, Verdonck LF. Chronic kidney disease after myeoablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1169-1175.
29. Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009; 302: 306-314.
30. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175-1183.
31. Felce D, Perry J. Quality of Life: its definition and measurement. Res Dev Disabi 1995; 16: 51-74.
32. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy measurement System: properties, applications and interpretation. Health Qual Life Outcomes 2003; 1: 79-86.
33. Pidala J, Kurland B, Chai X, Majhail N, Weisdorf DJ, Pavletic S etal. Patient-reported quality of life is associated with severity of chronic graft versus host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium. Blood 2011; 117: 4651-4657.